Internal Med Medical News about Colorectal Neoplasms Folic Acid Neoplasm Recurrence, Local

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma
American Journal of Clinical Nutrition, 10/29/09

Wu K et al. – These results do not support an overall protective effect of folic acid supplementation on adenoma recurrence. Folic acid supplementation may be beneficial among those with lower folate concentrations at baseline.

Methods

A double–blind, randomized trial among participants of 2 large prospective cohorts, the Health Professionals Follow–Up Study and the Nurses’ Health Study.
Participants were randomly assigned to receive folic acid (1 mg/d) (n = 338) or placebo (n = 334) for 3–6.5 y.
The primary endpoint was any new diagnosis of adenoma during the study period (May 1996–March 2004).
Secondary outcomes were adenoma by site, stage, and number of recurrent adenomas. Associations were also examined by plasma folate concentrations at baseline.

Results

Incidence of at least one recurrent adenoma was not significantly associated with folic acid supplementation.
Among participants with low plasma folate concentrations at baseline (<=7.5 ng/mL), those randomly assigned to receive folic acid experienced a significant decrease in adenoma recurrence, whereas for subjects with high folate concentrations at baseline (>7.5 ng/mL), supplemental folic acid had no significant effect.
Contrary to findings from another clinical trial, there was no evidence for an increased risk of advanced or multiple adenomas.

<< Previous
Using pedometers to monitor walking activity in outcome...

Next >>
What is most important is what comes across-Urological guidelines...